Enright Patrick G's Form 4 filing
Vera Therapeutics, Inc. (VERA) · filed Jun 25, 2025
- Accession no.
- 0000950170-25-090110
- Filed
- Jun 25, 2025
- Trade date
- Jun 23-24, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market purchases total $5.28M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Enright Patrick GCIK 0001253886 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 23, 2025 | Class A Common Stock | PPurchaseAcquired | +69,798 | $20.87 | +$1,456,684.26 | 1,784,083 | Indirect | |
| Jun 23, 2025 | Class A Common Stock | PPurchaseAcquired | +139,595 | $20.87 | +$2,913,347.65 | 3,569,522 | Indirect | |
| Jun 24, 2025 | Class A Common Stock | PPurchaseAcquired | +13,536 | $22.35 | +$302,529.6 | 1,797,619 | Indirect | |
| Jun 24, 2025 | Class A Common Stock | PPurchaseAcquired | +27,071 | $22.35 | +$605,036.85 | 3,596,593 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.